Get started
Author

Mark JM Magbanua

Differential Expression of Thrombospondin (THBS1) in Tumorigenic and Nontumorigenic Prostate Epithelial Cells in Response to a Chromatin-Binding Soy Peptide
2011 · Alfredo F. Galvez, Liping Huang, et al. · Nutrition and Cancer · 31
Isolation and Molecular Characterization of Circulating Tumor Cells
2017 · Park, John W, Magbanua, Mark Jesus M · Advances in experimental medicine and biology · 17
Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in the I-SPY 2 TRIAL
2019 · MJM Magbanua, L Brown-Swigart, et al. · Cancer Research · 9
Abstract P4-01-12: Low peripheral blood CD4/CD8 ratio at the time of surgery is a negative long-term prognostic factor in women with early stage breast cancer
2019 · MJM Magbanua, C Yau, et al. · Cancer Research · 2
5MO Pretreatment circulating tumor (ct)DNA predicts metastatic recurrence in patients (pts) with high-risk early breast cancer (eBC) enrolled in the I-SPY 2 trial
2025 · M. Magbanua, D. Wolf, et al. · ESMO Open · 1
PDF
314P The impact of changes in tumor mutational landscape during neoadjuvant therapy on tumor-informed ctDNA testing in breast cancer patients
2024 · M. Magbanua, S. Rivero-Hinojosa, et al. · Annals of Oncology · 1
PDF
53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression
2023 · Harriet T Rothschild, A Jo Chien, et al. · Journal of Clinical and Translational Science · 1
PDF
53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression – CORRIGENDUM
2023 · Harriet T Rothschild, A Jo Chien, et al. · Journal of Clinical and Translational Science · 1
PDF
Abstract P1-01-04: Comprehensive genomic characterization of circulating tumor cells (CTCs) in metastatic breast cancer (MBC) sheds light on the biology of blood-borne metastasis
2017 · MJ Magbanua, L Hauranieh, et al. · Cancer Research · 1
P4-07-17: Isolation of Highly Pure Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients for Gene Expression Analysis.
2011 · MJ Magbanua, L Hauranieh, et al. · Cancer Research · 1
Genome-wide copy number analysis of circulating tumor cells from patients (pts) with metastatic breast cancer (MBC).
2011 · M. J. M. Magbanua, E. Sosa, et al. · Journal of Clinical Oncology · 1
Gene expression profiling of circulating tumor cells from breast cancer patients
2006 · M. M. Magbanua, J. E. Lang, et al. · Journal of Clinical Oncology · 1
Abstract PS1-01-05: Pneumonitis but not other immune related adverse events (irAEs) associate with pre-treatment immune signatures in early-stage breast cancer patients receiving neoadjuvant immunotherapy (IO): results from 5 IO arms in I-SPY2
2026 · D. M. Wolf, H. Rugo, et al. · Clinical Cancer Research
Abstract PD6-07: Ctdna dynamics is most predictive of response in treatment-sensitive response-predictive subtypes of breast cancer: results from the I-SPY2 trial
2026 · M. Magbanua, D. Wolf, et al. · Clinical Cancer Research
Abstract PS4-02-01: Differential early response to neoadjuvant endocrine therapy in lobular versus non-lobular breast cancer on the Endocrine Optimization Pilot (EOP) of the I-SPY2 Trial
2026 · R. Mukhtar, P. Norwood, et al. · Clinical Cancer Research
Abstract PD6-03: Validation of MRI predictive models for treatment optimization in the I-SPY 2 TRIAL
2026 · W. Li, N. Onishi, et al. · Clinical Cancer Research
Abstract PS2-07-17: Characterizing circulating tumor cell (CTC) enumeration and phenotypic profiling in blood with synchronously obtained tissue in metastatic breast cancer (MBC) in TBCRC /AURORA US
2026 · K. V. Giridhar, W. C. Nenad, et al. · Clinical Cancer Research
Culture and Expansion of Circulating Tumor Cells from Breast Malignant Effusions as Organoids
2026 · Amirabbas Parizadeh, Shruti Warhadpande, et al. · Methods in molecular biology
Abstract P3-01-02: Detection of circulating tumor cells (CTC) in blood and disseminated tumor cells (DTC) in bone marrow at surgery identifies breast cancer patients (pts) with long-term risk of distant recurrence and breast cancer-specific death
2019 · MJM Magbanua, C Yau, et al. · Cancer Research
Abstract P2-01-01: Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study
2018 · MJ Magbanua, L Hendrix, et al. · Cancer Research
Abstract PD6-8: Prognostic value of disseminated tumor cells according to ER/PR and HER2 status in non-metastatic breast cancer
2013 · JS Lee, MJM Magbanua, et al. · Cancer Research
Abstract P2-01-05: Parallel DNA and RNA profiling of EpCAM-positive cells in blood of metastatic breast cancer (MBC) patients confirm their malignant nature
2012 · MJM Magbanua, L Hauranieh, et al. · Cancer Research
Diet-Influenced Chromatin Modification and Expression of Chemopreventive Genes by the Soy Peptide Lunasin
2011 · Alfredo Galvez, Liping Huang, et al. · CRC Press eBooks
Abstract PD04-10: Genome-Wide Copy Number Analysis of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients
2010 · MJM Magbanua, EV Sosa, et al. · Cancer Research
Gene expression in serial biopsies in locally advanced breast cancer patients who failed to respond to neoadjuvant chemotherapy.
2010 · M. M. Magbanua, S. E. Davis, et al. · Journal of Clinical Oncology
Works count: 25
Citation count: 67
H-index: 3
I10-index: 2
Year
Topic
Type